Event Group
Event Groups are part of the Adverse Events Module within the Results Section. They provide a way to organize and summarize adverse event data by grouping related events together.
Each Event Group typically represents a category or class of adverse events and includes statistical information such as the number of participants affected and at risk for different event types: deaths, serious events, and other events.
Event Group path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Group
Event Group
Ignite Creation Date:
2025-12-25 @ 12:17 AM
Ignite Modification Date:
2025-12-25 @ 10:19 PM
NCT ID:
NCT01710358
Group ID:
EG003
Title:
Placebo Treatment B
Description:
Placebo Treatment B (week 24-52).
Placebo administered orally (PO) once daily (QD) through Week 24 and placebo administered by subcutaneous (SC) injection every 2 weeks through Week 50.
At Week 24, participants were given baricitinib 4 milligram (mg) orally once daily through Week 52.
Starting at Week 16, participants who were nonresponders were rescued with baricitinib 4 mg orally once daily through Week 52.
Deaths Number Affected:
None
Deaths Number At Risk:
None
Serious Number Affected:
12
Serious Number At Risk:
306
Other Number Affected:
58
Other Number At Risk:
306
Study:
NCT01710358
Results Section:
NCT01710358
Adverse Events Module:
NCT01710358